Paul DiSilvestro
- Reproductive Medicine top 0.05%
- Ovarian cancer diagnosis and treatment 98
- Endometriosis Research and Treatment 10
- Obstetrics and Gynecology top 0.1%
- Endometrial and Cervical Cancer Treatments 59
- Oncology top 1%
- PARP inhibition in cancer therapy 26
- Cancer Research top 2%
-
- Intraperitoneal and Appendiceal Malignancies 18
-
- BRCA gene mutations in cancer 17
-
- Cervical Cancer and HPV Research 16
-
- Renal cell carcinoma treatment 10
- Co-authors
- Richard G. MooreMichael Craig MillerSteven J. SkatesAmy BrownD. Scott McMeekinRobert C. BastW. Jeffrey AllardRobert S. Mannel
- Journals
- New England Journal of Medicine (2 papers)Journal of Clinical Oncology (30 papers)Scientific Reports (1 paper)
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
Paul DiSilvestro
154 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Reproductive Medicine 3.9k
- Obstetrics and Gynecology 2.6k
- Oncology 2.0k
- Cancer Research 860
- Pathology and Forensic Medicine 719
Countries citing papers authored by Paul DiSilvestro
This map shows the geographic impact of Paul DiSilvestro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul DiSilvestro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul DiSilvestro more than expected).
Fields of papers citing papers by Paul DiSilvestro
This network shows the impact of papers produced by Paul DiSilvestro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul DiSilvestro. The network helps show where Paul DiSilvestro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul DiSilvestro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 13 | |
| 5 | 2022 | 47 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 2 | |
| 9 | 2020 | 47 | |
| 10 | Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancerbreakdown → | 2019 | 209 |
| 11 | 2018 | 4 | |
| 12 | 2018 | 1 | |
| 13 | 2017 | 20 | |
| 14 | 2017 | 41 | |
| 15 | 2017 | 92 | |
| 16 | 2016 | 31 | |
| 17 | Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy | 2015 | 3 |
| 18 | 2015 | 38 | |
| 19 | 2009 | 200 | |
| 20 | 2005 | 36 |
About Paul DiSilvestro
Paul DiSilvestro is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 159 papers that have together received 6.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (98 papers), Endometrial and Cervical Cancer Treatments (59 papers), PARP inhibition in cancer therapy (26 papers), Intraperitoneal and Appendiceal Malignancies (18 papers), BRCA gene mutations in cancer (17 papers), Cervical Cancer and HPV Research (16 papers), Renal cell carcinoma treatment (10 papers) and Endometriosis Research and Treatment (10 papers). The work is most often cited by research in Reproductive Medicine (3.9k citations), Obstetrics and Gynecology (2.6k citations) and Oncology (2.0k citations). Paul DiSilvestro has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Richard G. Moore, Michael Craig Miller, Steven J. Skates, Amy Brown, D. Scott McMeekin, Robert C. Bast, W. Jeffrey Allard, Robert S. Mannel, W Gajewski and David S. Miller. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.